Description
GW-0742 + SR-9011 Stack research stack
GW-0742 + SR-9011 Stack combines GW-0742, a PPAR-δ agonist, with SR-9011, a Rev-Erb agonist.
Product details
| Compound | GW-0742 and SR-9011 |
|---|---|
| Class | Two-compound research stack |
| Form | Tablets; Capsules; Injectables |
| Strength | 20mg per tablet/27ct/540mg; 20m per tablet/54ct/1080mg; 20mg per capsule/60ct/1.2grams; 10ml/70mg per ml = 700mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What GW-0742 + SR-9011 Stack research has examined
- GW-0742: PPAR-δ signalling.
- SR-9011: Rev-Erb and circadian research.
- Combination research: metabolic gene programmes.
Research interest does not establish a proven effect in humans.
Regulatory status
GW-0742 + SR-9011 Stack is a research blend. None of its components is approved for human use in this form, and it is supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Ostarine (MK-2866) + Cardarine (GW-501516) Stack · S4 Andarine + Ostarine (MK-2866) Stack · LGD-4033 + RAD-140 + S23 Stack · All bundles & stacks
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.